Sandoz Is Satisfied With US Pegfilgrastim Start

Promising Initial Signs For Ziextenzo

 
• By Aidan Fry
  
Good start
Sandoz says its Ziextenzo pegfilgrastim biosimilar is off to a good start in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products